1. “Common Terminology Criteria for Adverse Events (CTCAE) Version 5. Published: November 27, 2017. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute”, 2017. Available at: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_60 (Accessed: April 4, 2021).
2. Multikinase inhibitor-induced hand-foot skin reaction: a review of clinical presentation, pathogenesis, and management;Chanprapaph;Am J Clin Dermatol,2016
3. The effect of hand-foot skin reaction associated with the multikinase inhibitors sorafenib and sunitinib on health-related quality of life;Nardone;J Drugs Dermatol. JDD,2012
4. Tyrosine kinase inhibitors directed against the vascular endothelial growth factor receptor (VEGFR) have distinct cutaneous toxicity profiles: a meta-analysis and review of the literature;Massey;Support Care Cancer Off J Multinatl Assoc Support Care Cancer,2015
5. Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management;Miller;J Am Acad Dermatol,2014